Sophie Cunningham Said It. Women’s Tennis Turned It Into Politics.

Sophie Cunningham of the WNBA’s Indiana Fever sparked controversy when she publicly stated her belief that transgender women should not compete in women’s sports, framing the issue as one of fairness rather than exclusion. Her remarks quickly became a focal point of public discourse, igniting debates around gender, identity, and inclusivity in athletics. Around the same time, the Women’s Tennis Association (WTA) released a new eligibility policy that introduced a requirement for all female competitors to undergo a one-time genetic test for the SRY gene, linked to male sex development. While the timing of these developments appeared coincidental, the combined impact has shifted the focus of the transgender-athlete debate from individual statements to institutional policy decisions. The WTA’s updated policy marks a significant evolution in how women’s sports organizations approach gender verification. Previously, the association allowed transgender women to compete under certain conditions, including maintaining testosterone levels below 10 nmol/L for at least 12 months. By 2024, this threshold was lowered to 2.5 nmol/L over a 24-month period. Now, the organization is taking a more stringent stance, requiring genetic testing for the SRY gene as part of the eligibility process. This change reflects a broader trend among international sports federations, as they increasingly prioritize scientific validation over self-declaration or case-by-case assessments. This shift aligns with growing pressure from global sporting bodies to establish standardized criteria for female categories. World Athletics has implemented one-time SRY testing for athletes aiming to compete in the female division, effective from 2025. Similarly, World Boxing has mandated sex testing, citing concerns over safety and the integrity of competition. These measures have been influenced by the International Olympic Committee’s (IOC) 2026 policy, which restricts female-category eligibility at Olympic events, including the 2028 Los Angeles Games, to individuals confirmed as biological females via SRY screening. For the WTA, adopting similar procedures appears both a strategic move and a response to the looming deadline set by the IOC. The implications of these changes extend beyond mere regulation. They represent a fundamental transformation in how women’s sports define and enforce eligibility. Where once discussions centered on personal narratives and advocacy, the current landscape emphasizes institutional control, medical verification, and legal compliance. The WTA’s policy, while framed as a means to “promote equal athletic opportunities” and “maintain fair competition,” also raises questions about the balance between inclusivity and exclusivity. Athletes will now face tangible requirements, including undergoing genetic tests and adhering to strict hormonal standards, which could affect their ability to participate in competitive play. Critics argue that such policies risk reinforcing outdated stereotypes and subjecting female athletes to unnecessary scrutiny. Human Rights Watch has expressed concern that widespread sex testing constitutes a discriminatory practice, echoing historical patterns of invasive examination targeting women with diverse sex characteristics. Conversely, supporters view these measures as necessary steps to safeguard the integrity of women’s sports, ensuring that all participants meet objective criteria for eligibility. The U.N. Special Rapporteur Reem Alsalem has endorsed the IOC’s approach, stating it restores “dignity, fairness and safety for women and girls in Olympic sport.” As the debate continues, the next phase of contention is likely to involve procedural matters rather than ideological disputes. Questions remain about who will access test results, how appeals will be processed, and how athletes with intersex or trans identities will navigate the system. Additionally, the potential conflict between national privacy laws and international regulatory frameworks adds another layer of complexity. With the 2028 Los Angeles Games approaching, the pressure on governing bodies to finalize clear guidelines is intensifying, setting the stage for a new era in women’s sports governance.